Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Bionovate Technologies Corp.    BIIO

BIONOVATE TECHNOLOGIES CORP.

(BIIO)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

BIONOVATE TECHNOLOGIES : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K/A)

10/26/2020 | 10:55am EST

Item 1.01 Entry Into A Material Definitive Agreement.

On October 7, 2020, Bionovate Technologies Corp. (the "Company") entered into a Share Exchange Agreement (the "Share Exchange Agreement") facilitated between Evergreen Solutions, Ltd, a private Company ("Evergreen"), and Human Data AG, a private Switzerland Company ("Human Data").

Pursuant to the Share Exchange Agreement, in exchange for the acquisition of all of the outstanding Company shares which Evergreen owns, to wit, 54,270,000 shares (the "Exchange Shares"), the Company will receive 12,500 shares of Digital Diagnostics AG ("Digital") owned by Human Data, which equates to 25% of the currently issued shares of Digital.

The Share Exchange Agreement contains customary representations and warranties made by the Company, on the one hand, and Evergreen and Human Data on the other hand, made solely for the benefit of the other, which in certain cases are subject to specified exceptions and qualifications contained in the Share Exchange Agreement or in information provided pursuant to certain disclosure schedules to the Share Exchange Agreement.

Item 9.01 Financial Statements and Exhibits

The foregoing descriptions of the Share Exchange Agreement do not purport to be complete and are subject to, and are qualified in their entirety by, the full text of this agreement, which is filed herewith as Exhibit 10.1, and incorporated herein by reference.





2

© Edgar Online, source Glimpses

All news about BIONOVATE TECHNOLOGIES CORP.
11/27BIONOVATE REALIGNS ITS STRATEGY : from Quantify Yourself to Know Yourself
AQ
11/27BIONOVATE REALIGNS ITS STRATEGY : from Quantify Yourself to Know Yourself
GL
11/23BIONOVATE TECHNOLOGIES : Management's Discussion and Analysis of Financial Condi..
AQ
10/26BIONOVATE TECHNOLOGIES : Entry into a Material Definitive Agreement, Financial S..
AQ
10/20BIONOVATE TECHNOLOGIES : Regarding Share Transfere AGreement Human Data - Evergr..
AQ
10/19BIONOVATE TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
10/17BIONOVATE TECHNOLOGIES : picks up semanticom for international PR
AQ
10/17Bionovate Technologies picks up semanticom for international PR
GL
10/13BIONOVATE TECHNOLOGIES CORP. : Entry into a Material Definitive Agreement, Finan..
AQ
10/06BIONOVATE TECHNOLOGIES CORP. : Change in Directors or Principal Officers (form 8..
AQ
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -0,12 M - -
Net Debt 2020 0,23 M - -
P/E ratio 2020 -205x
Yield 2020 -
Capitalization 458 M 458 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 8,67%
Chart BIONOVATE TECHNOLOGIES CORP.
Duration : Period :
Bionovate Technologies Corp. Technical Analysis Chart | BIIO | US09074V2025 | MarketScreener
Income Statement Evolution
Managers
NameTitle
Aleksandar Vucak President, CEO, CFO, Secretary & Director
Sector and Competitors
1st jan.Capitalization (M$)
BIONOVATE TECHNOLOGIES CORP.0.00%458
DEUTSCHE PFANDBRIEFBANK AG-41.96%1 359